143 related articles for article (PubMed ID: 21162897)
21. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
[TBL] [Abstract][Full Text] [Related]
22. Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Dhadda AS; Bessell EM; Scholefield J; Dickinson P; Zaitoun AM
Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):197-202. PubMed ID: 24485884
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.
Soumarova R; Skrovina M; Bartos J; Gruna J; Wendrinski A; Czudek S; Kycina R; Parvez J
Eur J Surg Oncol; 2010 Mar; 36(3):251-6. PubMed ID: 19879716
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
[TBL] [Abstract][Full Text] [Related]
25. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
26. Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study.
Wang LW; Hsiao CF; Chen WT; Lee HH; Lin TC; Chen HC; Chen HH; Chien CR; Lin TY; Liu TW
J Surg Oncol; 2014 May; 109(6):580-5. PubMed ID: 24374744
[TBL] [Abstract][Full Text] [Related]
27. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
[TBL] [Abstract][Full Text] [Related]
28. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?
Jung KU; Kim HC; Park JO; Park YS; Park HC; Choi DH; Cho YB; Yun SH; Lee WY; Chun HK
J Surg Oncol; 2015 Mar; 111(4):439-44. PubMed ID: 25488390
[TBL] [Abstract][Full Text] [Related]
30. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
31. Short-term outcomes of laparoscopically assisted surgery for rectal cancer following neoadjuvant chemoradiotherapy: a single-center experience.
Hu JJ; Liang JW; Wang Z; Zhang XM; Zhou HT; Hou HR; Zhou ZX
J Surg Res; 2014 Apr; 187(2):438-44. PubMed ID: 24252856
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.
Chua YJ; Barbachano Y; Cunningham D; Oates JR; Brown G; Wotherspoon A; Tait D; Massey A; Tebbutt NC; Chau I
Lancet Oncol; 2010 Mar; 11(3):241-8. PubMed ID: 20106720
[TBL] [Abstract][Full Text] [Related]
33. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
[TBL] [Abstract][Full Text] [Related]
34. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
[TBL] [Abstract][Full Text] [Related]
36. A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer.
Velenik V; Ocvirk J; Oblak I; Anderluh F
Eur J Surg Oncol; 2010 Mar; 36(3):244-50. PubMed ID: 20042310
[TBL] [Abstract][Full Text] [Related]
37. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
38. Sphincter preservation therapy for rectal cancer.
Aitken C; Breen E; Mamon HJ
Clin Adv Hematol Oncol; 2003 Dec; 1(12):735-40. PubMed ID: 16258478
[TBL] [Abstract][Full Text] [Related]
39. Preoperative concurrent chemotherapy and radiotherapy in rectal cancer patients.
Ch'ang HJ; Jian JJ; Cheng SH; Liu MC; Leu SY; Wang FM; Tsai SY; Tsao MH; Lin HH; Huang AT; Sung JL
J Formos Med Assoc; 1998 Jan; 97(1):32-7. PubMed ID: 9481062
[TBL] [Abstract][Full Text] [Related]
40. Feasibility of modified short-course radiotherapy combined with a chemoradiosensitizer for T3 rectal cancer.
Beppu N; Matsubara N; Kakuno A; Doi H; Kamikonya N; Yamanaka N; Yanagi H; Tomita N
Dis Colon Rectum; 2015 May; 58(5):479-87. PubMed ID: 25850834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
